首页> 外文期刊>Pferdeheilkunde >Regenerative and innovative joint medication in the horse - Part 2: Efficacy end adverse effects of joint medication in the horse - a review of the literature. [German]Original Title Wirkungen und Nebenwirkungen der intraartikularen medikamentellen Therapie beim Pferd - eine Literaturubersicht - Teil 2: Regenerative und innovative intraartikulare medikamentelle Therapie beim Pferd.
【24h】

Regenerative and innovative joint medication in the horse - Part 2: Efficacy end adverse effects of joint medication in the horse - a review of the literature. [German]Original Title Wirkungen und Nebenwirkungen der intraartikularen medikamentellen Therapie beim Pferd - eine Literaturubersicht - Teil 2: Regenerative und innovative intraartikulare medikamentelle Therapie beim Pferd.

机译:马匹中的再生和创新关节药物-第2部分:马匹中联合药物的功效终点不良影响-文献综述。 [德国]关节内药物治疗在马中的原始标题效应和副作用-文献综述-第2部分:马中关节再生和创新性药物治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

The pathogenesis of osteoarthritis in the horse is a complex and incompletely understood process of joint degeneration. Many cases have proven to be refractory to intra-articular medication using conventional therapeutic agents. Over recent years this has encouraged the development of several new techniques utilizing regenerative preparations. The potential advantage of the use of these therapies is that they should allow a more complete restoration of joint health. In the future it appears likely that gene-therapy will permit the regrowth and repair of damaged cartilage along with healthy joint fluid. The objective of this research is to identify the clinically relevant information about regenerative and innovative intra-articular joint medications such as Pentosanpolysulphate, Autologous Conditioned Serum, Platelet Rich Plasma, Stem Cell techniques and Gene-Therapy based on a review of current in vitro- and in vivo studies.
机译:马骨关节炎的发病机理是关节退化的复杂且尚未完全了解的过程。已证明许多情况下使用常规治疗剂对关节内药物难以治疗。近年来,这鼓励了利用再生制剂的几种新技术的发展。使用这些疗法的潜在优势在于,它们应该可以使关节健康得到更完全的恢复。将来,基因治疗似乎有可能使受损的软骨以及健康的关节液得以再生和修复。这项研究的目的是基于对当前体外和体外治疗的回顾,确定有关再生和创新性关节内联合药物(如戊聚糖多硫酸盐,自体条件血清,富含血小板的血浆,干细胞技术和基因疗法)的临床相关信息。体内研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号